[The plasma level and gene expression in peripheral blood of interleukin-35 in patients with sarcoidosis and its clinical significance].

Findings showed that IL-targeting biologics were associated with a 35% lower rate of serious infections ... Researchers conclude that biologics targeting interleukin pathways may be safer ...